The network funds pilot and exploratory studies, grant planning activities, and small collaboration grants. The goals of these grant programs are to support early-stage research in deprescribing that has high potential to develop into future large projects, to catalyze research in areas that are of particular importance to the field, to support junior investigator development, and to promote collaborations that will lead to future research projects.
- Pilot awards
- Grant planning awards
- Collaboration awards
- Learn about network grantees and their projects
Applications for the 2020-2021 cycle are now closed. We encourage you to Join the Network for updates about the 2021-2022 cycle.
Pilot and Grant Planning Awards
The pilot award supports research related to deprescribing that provides key preliminary data, proof of concept, or developmental work that offers a clear pathway to future, larger-scale studies and career development for the investigators involved. This award is geared primarily, but not exclusively, toward junior investigators. All topics related to deprescribing are welcome. Proposals should have a plan for engaging stakeholders in the research process; the network can guide interested investigators on strategies to achieve this (see the RFA for details). Use of other network resources such as consultations with experts are welcomed although not required.
Pilot awards are for 1 year with a maximum budget of $60,000 in total costs (directs plus indirects). Exceptions on duration and budget may be granted for exceptional circumstances. Pilot award proposals will be reviewed using an abbreviated, NIH-style review process that includes input from stakeholder representatives. Proposals will be judged on innovation, scientific rigor, feasibility, investigators and environment, potential to lead to future larger-scale work, stakeholder engagement, and relevance to priority areas and aging.
For more information, including instructions on how to apply, see the Request For Applications (RFA). You can refer to the following sample documents for the budget: budget template, Scope of Work, and budget justification. A webinar for interested applicants will be held according to the timeline listed below; please review our roster of webinars for more information. The network anticipates funding approximately 4 to 5 awards (comprising both pilot and grant planning awards) each year.
Grant Planning Award
Grant planning awards are intended to fund grant preparation activities that will lead to submission of large grant proposals such as multisite clinical trials. Examples of activities such awards may fund include meetings and travel for study investigators to develop the proposal under consideration or administrative costs to engage multiple clinical sites into a multisite research trial planning process. For more information, including instructions on how to apply, see the Request For Applications (RFA). You can refer to the following sample documents for the budget: budget template, Scope of Work, and budget justification. Potential applicants for grant planning awards are also strongly encouraged to contact us to ensure the mechanism is an appropriate fit.
Timeline for applications:
Applications for the 2020-2021 cycle are now closed.
Please Join the Network for updates about the 2021-2022 cycle.
Webinar for applicants
(optional but encouraged)
Letter of intent
(optional but encouraged)
Application due date
March 9, 2020
Notification of awards
Award start date
August – September 2020
Collaboration awards comprise small grants (generally in the range of $500 – $5000) to incubate topic- and site-specific collaborative efforts. Examples of potential awards include a grant to convene a mini-summit for investigators in a geographic area who might be interested in collaborating on deprescribing research, or seed funding for a geographically dispersed group of investigators who were interested in collaborating around an area of common interest. Applications will comprise a brief proposal and budget justification.
Timeline: Applications are reviewed on a rolling basis.